<DOC>
	<DOCNO>NCT00644683</DOCNO>
	<brief_summary>Premenopausal woman diagnose breast cancer frequently treat chemotherapy . Chemotherapy affect ovary , effect range temporary loss menstrual period permanent menopause . It difficult predict individual 's ovarian function affect chemotherapy . There number hormone measure blood relate fertility ovarian function . The level hormone may change chemotherapy , may relate effect chemotherapy ovary . In study , plan enroll 28 woman range age 25 50 diagnose breast cancer treat chemotherapy . We check blood level hormone , immediately , 1 year treatment chemotherapy . We check blood test study ; type chemotherapy give patient oncologist . We also ask question factor influence level hormone , number child , age menopause family member , smoke history . The result study use help u develop future study look change ovarian function chemotherapy , effect breast cancer therapy , endocrine therapy , ovary .</brief_summary>
	<brief_title>A Pilot Observational Study Assess Changes Biochemical Parameters Ovarian Reserve With Chemotherapy</brief_title>
	<detailed_description />
	<criteria>Subjects must woman histologically confirm invasive adenocarcinoma breast ( stage I , II , III ) evidence metastatic disease . Patients must plan receive neoadjuvant adjuvant chemotherapy . Patients may receive concurrent trastuzumab indicate . If patient yet undergone final surgical resection , must highly likely ( require definite ) patient treat adjuvant chemotherapy . Patients must : Reached 25th birthday yet reach 51st birthday time study enrollment , AND Had menses within 3 month prior start chemotherapy Patients must receive prior cytotoxic chemotherapy oncologic , rheumatologic , dermatologic condition . Patients must prior bilateral oophorectomy pelvic radiation , must prior hysterectomy ECOG performance status 0 2 Pregnant nursing woman may participate . Women reproductive potential must agree use effective nonhormonal contraceptive method , condom , tubal ligation , nonhormonal intrauterine device , partner sterilization , abstinence chemotherapy . All patient must inform investigational nature study give write informed consent accordance institutional federal guideline .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>premenopausal woman breast cancer</keyword>
</DOC>